Drugmakers post positive earnings for 2018
Thursday, February 14, 2019 - 20:00
in Mathematics & Economics
The industry’s outlook is sunny, with an emphasis on expensive new medicines despite pricing pressure
The industry’s outlook is sunny, with an emphasis on expensive new medicines despite pricing pressure